Dealflow | June 4, 2020

OurCrowd eyes $100 million for “pandemic tech” startups

Jessica Pothering
ImpactAlpha Editor

Jessica Pothering

ImpactAlpha, June 4 – Israel-based venture investing platform OurCrowd wants to support emerging health and medical tech innovations, as well as startups addressing social needs, like education access.

“We must plan for future pandemics because this story is just beginning,” wrote OurCrowd’s Jonathan Medved.

As many as 20 of OurCrowd’s portfolio companies are already working on solutions related to the COVID crisis, like vaccine developer MigVaxs.

Last year, OurCrowd launched its first impact fund, linking its cut of returns to impact targets (see, Israel’s OurCrowd is targeting the Sustainable Development Goals – and measuring its own impact).